Automotive supplier Delphi Corporation has announced that it will no longer offer health care benefits to its salaried Medicare eligible retirees. Look for more companies to cancel retiree health benefits â€“especially drug benefitsâ€”as the Medicare drug benefit kicks in.
Health Business Blog
Health care business consultant and policy expert David E. Williams share his views
It’s well documented that computerized physician order entry systems (CPOE) reduce medication errors in the hospital. However, the March 9 issue of the Journal of the American Medical Association (JAMA) reports that…
…a widely used CPOE system facilitated 22 types of medication error risks. Examples include fragmented CPOE displays that prevent a coherent view of patients’ medications, pharmacy inventory displays mistaken for dosage guidelines, ignored antibiotic renewal notices placed on paper charts rather than in the CPOE system, separation of functions that facilitate double dosing and incompatible orders, and inflexible ordering formats generating wrong orders. Three quarters of the house staff reported observing each of these error risks, indicating that they occur weekly or more often.
Technology is a tool to improve safety, quality, and efficiency, but it’s not a panacea. Good system design and implementation is as critical and difficult in medicine as in any other sector. IT systems usually fail to deliver on their promise at first, and sometimes cause new problems. It takes a while to produce substantial improvements, so hospitals should get started now to gain experience and learn from their mistakes.
There are two good patient care articles in today’s New York Times. Insurrection on the Mighty Ship of Health Care, written from a doctor’s perspective, describes the ultimately futile attempt of a patient to maintain her humanity in the hospital.
Doctors are often caught in this uneasy halfway house between medical reality and the wishes of a patient, a patient who probably knows plenty, but insists on putting on a happy face, and it raises a basic question. Is it up to us to rub a patient’s face in her own frightening situation, to overwhelm the tricks and sleights of hand used to maintain sanity?
A Fight for Full Disclosure of the Possible Pain describes the author’s experience of undertreatment for pain after knee surgery, and laments the Drug Enforcement Agency’s policies, which are causing doctors to be fearful about prescribing adequate pain relief.
[A] mass uprising by doctors and patients in support of legitimate pain treatment is overdue.
The Detroit News reports that companies are beginning to offer consumers genetic screening tests to indicate predisposition for various diseases including breast and lung cancer, blood clotting, and cystic fibrosis. The customer takes a swab from inside the cheek, mails it in, and views the test result on line. Tests cost a few hundred dollars.
I’m a proponent of consumer choice and access, but there are problems with these tests:
- One reason the tests are being offered on a consumer pay model is that it doesn’t make sense financially for insurers to pay for population screening for most disorders
- “Predisposition” is a loose term –the genetic mutations identified may account for only a small proportion of the risk. Many people with a genetic predisposition will never get the disease –but once they have the test result they will be forever worried
- In many cases there’s not much a consumer can do to change the likelihood of disease onset
Today’s Boston Globe reports that older people with chronic illness receive less aggressive treatment than younger patients, and that age bias is often the cause. A few reasons are given:
- Older people are often excluded from drug trials. As a result there isn’t good information on appropriate dosing or efficacy
- Doctors assume older people won’t be able to tolerate aggressive treatments
- Older people often confuse chronic conditions with the normal aging process. And doctors apparently share this view to some extent. The Globe cites a survey in the Journal of Gerontology indicating that 35 percent of doctors believed increased blood pressure was a normal consequence of aging, although it is not
I’ve seen some evidence of this problem recently:
- In my consulting work on clinical protocol development, physicians conducting studies on behalf of pharmaceutical companies complained that the studies insisted on too many exclusion criteria (which would tend to knock out older people taking multiple medications). These criteria contribute little to the outcome of the trials, but severely limit the generalizability of the results
- An older relative of mine was initially denied chemotherapy due to his age. When the family pushed hard for it, the doctors went along and he responded well to the chemo
One of the advantages of Mark McClellan’s leadership and the new Medicare drug benefit is that we are already seeing a push at the Federal level for treatments to be tested on older people.